中国医学创新  2025, Vol. 22 Issue (13): 16-20    DOI: 10.3969/j.issn.1674-4985.2025.13.004
Article Current Issue | Archive | Adv Search |
Trastuzumab + Paclitaxel and Epirubicin in the Treatment of HER2 Positive Breast Cancer
LIU Xiaoying
First-author's address: Department of Pharmacy, Nanchang People's Hospital, Nanchang 330002, China
© 2016 中国医学创新 editorial
Address: Beijing south cellular road number five      Postcodes: 100055